calendar

Mar 18, 2026grant166d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — Targeting Lethal mCRPC with siRNA TherapeuticsUniversity of California San Diego

CA grant. $410,933. PI: STEVEN F DOWDY

Mar 18, 2026grant166d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Epigenetic Regulation of Hypothalamic Energy Homeostasis

DK grant. $664,240. PI: Isin Cakir

Mar 18, 2026grant166d agoAUBURN UNIVERSITY AT MONTGOMERY — BRE-SPAD at Auburn University at Montgomery

GM grant. $554,945. PI: Douglas W Leaman

Mar 18, 2026grant166d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Novel targeted combinatorial therapy for castration-resistant prostate cancer

CA grant. $658,492. PI: Song Li

Mar 18, 2026grant166d agoUT SOUTHWESTERN MEDICAL CENTER — Lipid Droplets

DK grant. $25,000. PI: Mike Henne

Mar 18, 2026grant166d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — Progressive Clinical Team-Based Design and Skill-Building Across All Undergra...University of California San Diego

EB grant. $21,600. PI: Reem Khojah

Mar 18, 2026grant166d agoSTANFORD UNIVERSITY — Threading the needle: Development of Novel MR Methods for Effective Control o...Stanford University

CA grant. $593,557. PI: Lawrence D Recht

Mar 18, 2026grant166d agoUNIVERSITY OF MARYLAND BALTIMORE — Associations between actigraphy-derived circadian rest-activity rhythms and c...

CA grant. $411,334. PI: Amber Simmons Kleckner

Mar 19, 2026approval165d agoDUOPA (CARBIDOPA) — FDA approvalcarbidopa

Sponsor: ABBVIE. Form: SUSPENSION. Route: ENTERAL

Mar 19, 2026approval165d agoRIFAXIMIN — FDA approvalSalix Pharmaceuticals Ltd

Sponsor: ACTAVIS LABS FL INC. Form: TABLET. Route: ORAL

Mar 19, 2026approval165d agoRIFABUTIN — FDA approvali3 Pharmaceuticals LLC

Sponsor: I3 PHARMS. Form: CAPSULE. Route: ORAL

Mar 19, 2026approval165d agoSTALEVO 75 (CARBIDOPA) — FDA approvalcarbidopa

Sponsor: ORION PHARMA. Form: TABLET. Route: ORAL

full page →(foscarbidopa + foslevodopa) →fda approvals ↗

Mar 19, 2026approval165d agoVYALEV (FOSCARBIDOPA) — FDA approval(foscarbidopa + foslevodopa)

Sponsor: ABBVIE. Form: SOLUTION. Route: SUBCUTANEOUS

Mar 19, 2026approval165d agoWEGOVY (SEMAGLUTIDE) — FDA approvalNovo Nordisk AS

Sponsor: NOVO. Form: TABLET. Route: ORAL

full page →OPUVIZ →fda approvals ↗

Mar 19, 2026approval165d agoOPUVIZ (AFLIBERCEPT-YSZY) — FDA approvalOPUVIZ

Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTABLE. Route: INJECTION

Mar 19, 2026approval165d agoVALGANCICLOVIR HYDROCHLORIDE — FDA approvalVALGANCICLOVIR HYDROCHLORIDE

Sponsor: MICRO LABS. Form: FOR SOLUTION. Route: ORAL

full page →VALGANCICLOVIR HYDROCHLORIDE →fda approvals ↗

Mar 19, 2026approval165d agoWEGOVY (SEMAGLUTIDE) — FDA approvalNovo Nordisk AS

Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS

Mar 19, 2026approval165d agoFLAVALTA (EPINEPHRINE BITARTRATE) — FDA approvalDe Motu Cordis Pty Ltd

Sponsor: DEPROCO. Form: SOLUTION. Route: INJECTION

Mar 19, 2026approval165d agoDHIVY (CARBIDOPA) — FDA approvalAvion Pharmaceuticals LLC

Sponsor: AVION PHARMS. Form: TABLET. Route: ORAL

Mar 19, 2026approval165d agoRYTARY (CARBIDOPA) — FDA approvalOrganon & Co.

Sponsor: IMPAX. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →dexmethylphenidate hydrochloride ER →fda approvals ↗

Mar 19, 2026approval165d agoDEXMETHYLPHENIDATE HYDROCHLORIDE — FDA approvaldexmethylphenidate hydrochloride ER

Sponsor: AUROLIFE PHARMA LLC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

Mar 19, 2026approval165d agoDEXMETHYLPHENIDATE HYDROCHLORIDE — FDA approvaldexmethylphenidate hydrochloride ER

Sponsor: AUROLIFE PHARMA LLC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →dexmethylphenidate hydrochloride ER →fda approvals ↗

Mar 19, 2026approval165d agoDEXMETHYLPHENIDATE HYDROCHLORIDE — FDA approvaldexmethylphenidate hydrochloride ER

Sponsor: AUROLIFE PHARMA LLC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →dexmethylphenidate hydrochloride ER →fda approvals ↗

Mar 19, 2026approval165d agoSINEMET CR (CARBIDOPA) — FDA approvalcarbidopa

Sponsor: ORGANON LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

Mar 19, 2026approval165d agoCREXONT (CARBIDOPA) — FDA approvalOrganon & Co.

Sponsor: IMPAX. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →setmelanotide →fda approvals ↗

Mar 19, 2026approval165d agoIMCIVREE (SETMELANOTIDE ACETATE) — FDA approvalsetmelanotide

Sponsor: RHYTHM. Form: SOLUTION. Route: SUBCUTANEOUS

Mar 19, 2026approval165d agoADRENACLICK (EPINEPHRINE) — FDA approvalViatris Inc

Sponsor: IMPAX. Form: INJECTABLE. Route: INTRAMUSCULAR, SUBCUTANEOUS

Mar 19, 2026approval165d agoSINEMET (CARBIDOPA) — FDA approvalcarbidopa

Sponsor: ORGANON. Form: TABLET. Route: ORAL

full page →EPHEDRINE SULFATE →fda approvals ↗

Mar 19, 2026approval165d agoEPHEDRINE SULFATE — FDA approvalEPHEDRINE SULFATE

Sponsor: FRESENIUS KABI USA. Form: SOLUTION. Route: INTRAVENOUS

Mar 19, 2026approval165d agoLIDOCAINE HYDROCHLORIDE — FDA approvalInternational Medication Systems Ltd

Sponsor: VIWIT PHARM. Form: INJECTABLE. Route: INJECTION

Mar 19, 2026grant165d agoUNIVERSITY OF COLORADO — Splicing-mediated dysregulation of interferon signaling in cancer

CA grant. $385,333. PI: Edward Bo-yi Chuong

Mar 19, 2026grant165d agoPURDUE UNIVERSITY — Dissecting the role of tumor suppressing microRNAs in angiosarcoma

CA grant. $437,654. PI: Jason A. Hanna

Mar 19, 2026grant165d agoUNIVERSITY OF CALIFORNIA-IRVINE — Harnessing Nutritional Modulation to Enhance Cancer Drug Potency

CA grant. $403,686. PI: Christopher J. Halbrook

Mar 19, 2026grant165d agoPORTERCARE ADVENTIST HEALTH SYSTEM — Fibrinolysis Dysfunction Impact on Graft Function in Liver Transplantation

HL grant. $74,631. PI: Hunter B Moore

Mar 20, 2026approval164d agoKETALAR (KETAMINE HYDROCHLORIDE) — FDA approvalPar Pharmaceutical Inc

Sponsor: PH HEALTH. Form: INJECTABLE. Route: INJECTION

full page →DEXMEDETOMIDINE HYDROCHLORIDE →fda approvals ↗

Mar 20, 2026approval164d agoDEXMEDETOMIDINE HYDROCHLORIDE — FDA approvalDEXMEDETOMIDINE HYDROCHLORIDE

Sponsor: GLAND. Form: INJECTABLE. Route: INJECTION

Mar 20, 2026approval164d agoDEXMEDETOMIDINE HYDROCHLORIDE — FDA approvalDEXMEDETOMIDINE HYDROCHLORIDE

Sponsor: GLAND. Form: INJECTABLE. Route: INJECTION

full page →DEXMEDETOMIDINE HYDROCHLORIDE →fda approvals ↗

Mar 20, 2026approval164d agoXeomin (incobotulinumtoxinA) — FDA approvalMerz Pharmaceuticals LLC

Sponsor: MERZ PHARMS. Form: INJECTABLE. Route: INJECTION

full page →doxycycline ER →fda approvals ↗

Mar 20, 2026approval164d agoDOXYCYCLINE — FDA approvaldoxycycline ER

Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL

Mar 20, 2026approval164d agoATONCY (ATOMOXETINE HYDROCHLORIDE) — FDA approvalPrasco LLC

Sponsor: MAP77. Form: SOLUTION. Route: ORAL

full page →nivolumab →fda approvals ↗

Mar 20, 2026approval164d agoOPDIVO (NIVOLUMAB) — FDA approvalnivolumab

Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION

Mar 20, 2026approval164d agoMEPRON (ATOVAQUONE) — FDA approvalatovaquone

Sponsor: GLAXOSMITHKLINE LLC. Form: SUSPENSION. Route: ORAL

full page →atovaquone →fda approvals ↗

Mar 20, 2026approval164d agoCARBAMAZEPINE — FDA approvalcarbamazepine ER

Sponsor: ALEMBIC. Form: TABLET. Route: ORAL

full page →carbamazepine ER →fda approvals ↗

Mar 20, 2026approval164d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Mar 20, 2026approval164d agoEPIPEN E Z PEN (EPINEPHRINE) — FDA approvaladrenaline

Sponsor: VIATRIS. Form: INJECTABLE. Route: INTRAMUSCULAR

full page →adrenaline →fda approvals ↗

Mar 20, 2026approval164d agoCARBAMAZEPINE — FDA approvalcarbamazepine ER

Sponsor: TORRENT PHARMS. Form: TABLET, CHEWABLE. Route: ORAL

full page →carbamazepine ER →fda approvals ↗

Mar 20, 2026approval164d agoCARBAMAZEPINE — FDA approvalcarbamazepine ER

Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL

full page →carbamazepine ER →fda approvals ↗

Mar 20, 2026approval164d agoLIDOCAINE HYDROCHLORIDE — FDA approvalLaryng-O-Jet

Sponsor: QUAGEN. Form: SOLUTION. Route: ORAL

full page →Laryng-O-Jet →fda approvals ↗

Mar 20, 2026grant164d agoUNIVERSITY OF NEW HAVEN — Deciphering the role of the novel long non-coding RNA LINC01896 in glioblasto...

NS grant. $69,600. PI: RASMANI HAZRA